Real-time enrollment status for this vascular ehlers-danlos syndrome clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 4:03 PM UTC
| NCT Number | NCT05432466 |
| Recruiting Status | Recruiting |
| Condition | Vascular Ehlers-Danlos Syndrome |
| Phase | PHASE3 |
| Target Enrollment | 150 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Acer Therapeutics Inc. |
| Last Updated on CT.gov | August 24, 2025 (Aug 24, 2025) |
As of July 19, 2026: Clinical trial NCT05432466 is currently recruiting participants. This phase3 study for vascular ehlers-danlos syndrome is actively seeking new participants at 1 location across the United States. The study is sponsored by Acer Therapeutics Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05432466 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05432466 was last updated Aug 24, 2025 (August 24, 2025). HelloStudys verifies this status automatically.